Login

Thinkific Labs Inc., a publicly traded company on the TSX , owns the trademark Thinkific. 00:10:00

Share On Facebook Share On Twitter

Greg Smith BCom, LLB, Chief Executive Officer, Co-Founder of Thinkific

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Talent to build great companies can come from anywhere|Jixun Foo,Global Managing Partner,GGV Capital
00:10:00
Ariel Investments' Vlad Byalik on Favorable Picks in Korean Banking and Philippine Real Estate Stocks
00:10:00
Our President and CEO highlights three key focus areas driving DXC Technology's unique value and business growth.|Raul Fernandez is president and chief executive officer of DXC Technology
00:10:00
The Breakfast Show features discussions with Kjerstin Braathen, CEO of DNB, and Ziv Cohen, CEO of Paygilant.|Kjerstin Braathen, CEO of DNB
00:10:00
Initiator Pharma's HealthCare Webinar on Penser Play discusses biotech developments, while TV4's Nyhetsmorgon covers the UN's new goals.
00:10:00
Martin Cabrera Jr.: Empowering the Latino Community Through Wealth Creation
00:10:00
Fostering Global Investment Synergies: Iqbal Khan of Credit Suisse on Building an Investment Community, Sharing Expertise, and Facilitating Co-Investments
00:10:00
To consistently grow capital through investment|Clive R Holmes,Managing Partner,Silverfern CoInvestment Partners
00:10:00
The Secrets of Early Stage Investing|Daniel Gulati,Founder and Managing Partner, Treble Capital
00:00:00
Explains why getting the COVID-19 vaccine is more important than ever - John (Jack) C. O'Horo, M.D. , Mayo Clinic
00:10:00
Understanding the Impact: A Deep Dive into Blockchain Applications in Real Estate | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
Insights into Venture Capital with Bill Comfort

© 2026 Nehu